Investments
169Portfolio Exits
37Funds
8
Want to inform investors similar to GF Xinde Investment Management Co. about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest GF Xinde Investment Management Co. News
Mar 20, 2019
BGI-Backed Chinese Biotech Start-Up GenoImmune Raises $18M Series A Round Chinese biotech start-up GenoImmune has secured RMB120 million (US$17.87 million) in a series A round of financing led by GF Xinde Investment Management Co., a private equity affiliate of GF Securities, said GenoImmune in a statement released on Wednesday. GenoImmune was founded in February 2017 in central China’s Wuhan city to specialize in the immunotherapy […] China News
GF Xinde Investment Management Co. Investments
169 Investments
GF Xinde Investment Management Co. has made 169 investments. Their latest investment was in GenScript ProBio as part of their Series C on January 1, 2023.
GF Xinde Investment Management Co. Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
1/18/2023 | Series C | GenScript ProBio | $220M | Yes | 7 | |
1/18/2023 | Series A - II | Taijie Weiye | Yes | 1 | ||
1/9/2023 | Series B | Sifary Medical Technology | Yes | 3 | ||
12/28/2022 | Series B | |||||
12/27/2022 | Seed VC - III |
Date | 1/18/2023 | 1/18/2023 | 1/9/2023 | 12/28/2022 | 12/27/2022 |
|---|---|---|---|---|---|
Round | Series C | Series A - II | Series B | Series B | Seed VC - III |
Company | GenScript ProBio | Taijie Weiye | Sifary Medical Technology | ||
Amount | $220M | ||||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 7 | 1 | 3 |
GF Xinde Investment Management Co. Portfolio Exits
37 Portfolio Exits
GF Xinde Investment Management Co. has 37 portfolio exits. Their latest portfolio exit was Pagoda on January 16, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
1/16/2023 | IPO | Public | 1 | ||
1/12/2023 | Corporate Majority | 2 | |||
9/9/2022 | IPO | Public | 4 | ||
GF Xinde Investment Management Co. Fund History
8 Fund Histories
GF Xinde Investment Management Co. has 8 funds, including Zhuhai GF Xinde Houyuan Equity Investment Fund LP.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
11/27/2014 | Zhuhai GF Xinde Houyuan Equity Investment Fund LP | Diversified Private Equity | Closed | 1 | |
3/11/2014 | Zhuhai GF Xinde Alpha Industry Fund I | ||||
珠海康远投资企业（Zhuhai Kangyuan Investment Enterprise） | |||||
GF Coastal Industry (Dalian) Fund | |||||
Yan An Industry Integration & Upgrade Mergers & Acquisiton Fund |
Closing Date | 11/27/2014 | 3/11/2014 | |||
|---|---|---|---|---|---|
Fund | Zhuhai GF Xinde Houyuan Equity Investment Fund LP | Zhuhai GF Xinde Alpha Industry Fund I | 珠海康远投资企业（Zhuhai Kangyuan Investment Enterprise） | GF Coastal Industry (Dalian) Fund | Yan An Industry Integration & Upgrade Mergers & Acquisiton Fund |
Fund Type | Diversified Private Equity | ||||
Status | Closed | ||||
Amount | |||||
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.